Cancer: A Growing Challenge in Iran
Cancer is one of the leading causes of mortality worldwide, and Iran is no exception. The country has witnessed a steady increase in cancer incidence over the past few decades, driven by factors such as population growth, aging, lifestyle changes, and environmental influences. According to recent statistics, cancer accounts for approximately 14% of deaths in Iran, making it the third leading cause of death after cardiovascular diseases and accidents.
The most prevalent cancers in the country include breast, colorectal, gastric, and lung cancers. Early diagnosis remains a challenge, as many cases are detected at advanced stages, reducing the likelihood of successful treatment. The opening of the Ayatollah Rafsanjani Hospital aims to address this gap by promoting early detection and providing comprehensive care under one roof.
Advancing Research and Innovation
Beyond patient care, the Ayatollah Rafsanjani Hospital aspires to become a hub for cancer research and innovation. The facility is equipped with modern laboratories dedicated to studying cancer biology, genetics, and treatment modalities. Collaborative partnerships with universities, research institutions, and international organizations are expected to drive groundbreaking discoveries and improve outcomes for cancer patients.